TY - JOUR
T1 - The relevance of gender in tumor-influencing epigenetic traits
AU - Sarne, Victoria
AU - Braunmueller, Sandrina
AU - Rakob, Lisa
AU - Seeboeck, Rita
N1 - Funding Information:
Funding: This research was funded by Österreichische Forschungsförderungsgesellschaft; Programm Talente, FEMtech Forschungsprojekte; .FFG Austria, grant number 849800.
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2019/1/28
Y1 - 2019/1/28
N2 - Tumorigenesis as well as the molecular orchestration of cancer progression are very complex mechanisms that comprise numerous elements of influence and regulation. Today, many of the major concepts are well described and a basic understanding of a tumor’s fine-tuning is given. Throughout the last decade epigenetics has been featured in cancer research and it is now clear that the underlying mechanisms, especially DNA and histone modifications, are important regulators of carcinogenesis and tumor progression. Another key regulator, which is well known but has been neglected in scientific approaches as well as molecular diagnostics and, consequently, treatment conceptualization for a long time, is the subtle influence patient gender has on molecular processes. Naturally, this is greatly based on hormonal differences, but from an epigenetic point of view, the diverse susceptibility to stress and environmental influences is of prime interest. In this review we present the current view on which and how epigenetic modifications, emphasizing DNA methylation, regulate various tumor diseases. It is our aim to elucidate gender and epigenetics and their interconnectedness, which will contribute to understanding of the prospect molecular orchestration of cancer in individual tumors.
AB - Tumorigenesis as well as the molecular orchestration of cancer progression are very complex mechanisms that comprise numerous elements of influence and regulation. Today, many of the major concepts are well described and a basic understanding of a tumor’s fine-tuning is given. Throughout the last decade epigenetics has been featured in cancer research and it is now clear that the underlying mechanisms, especially DNA and histone modifications, are important regulators of carcinogenesis and tumor progression. Another key regulator, which is well known but has been neglected in scientific approaches as well as molecular diagnostics and, consequently, treatment conceptualization for a long time, is the subtle influence patient gender has on molecular processes. Naturally, this is greatly based on hormonal differences, but from an epigenetic point of view, the diverse susceptibility to stress and environmental influences is of prime interest. In this review we present the current view on which and how epigenetic modifications, emphasizing DNA methylation, regulate various tumor diseases. It is our aim to elucidate gender and epigenetics and their interconnectedness, which will contribute to understanding of the prospect molecular orchestration of cancer in individual tumors.
KW - Carcinogenesis
KW - DNA methylation
KW - Epigenetics
KW - Gender medicine
KW - Precision medicine
KW - Sex
KW - Tumor marker
UR - http://www.scopus.com/inward/record.url?scp=85082108534&partnerID=8YFLogxK
U2 - 10.3390/epigenomes3010006
DO - 10.3390/epigenomes3010006
M3 - Review article
C2 - 34991275
AN - SCOPUS:85082108534
SN - 2075-4655
VL - 3
JO - Epigenomes
JF - Epigenomes
IS - 1
M1 - 6
ER -